当前位置:首页 - 行情中心 - 春立医疗(688236) - 财务分析

春立医疗

(688236)

  

流通市值:50.68亿  总市值:67.39亿
流通股本:2.88亿   总股本:3.84亿

春立医疗(688236)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.62亿元,每股收益0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益304867.35万元,未分配利润141375.22万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产363176.80万元,负债58309.45万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入216,972,373.231,045,766,405.34756,093,897.4487,596,405.66
营业总成本152,107,504.3722,853,785.21515,865,735.32333,777,775.81
其他经营收益
营业利润68,048,737.03302,245,079.93211,727,931.57127,313,219.41
利润总额68,014,570.8301,711,713.59211,788,696.95127,312,520.25
净利润61,681,083.77272,625,119.37191,612,423.86114,481,155.04
每股收益
其他综合收益----
综合收益总额61,681,083.77272,625,119.37191,612,423.86114,481,155.04
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,976,486,615.193,011,500,050.42,900,888,254.672,849,499,294.64
非流动资产:
非流动资产合计655,281,404.74649,634,810.73639,436,646.6639,308,726.91
资产总计3,631,768,019.933,661,134,861.133,540,324,901.273,488,808,021.55
流动负债:
流动负债合计488,914,115.34578,602,954.95458,167,274.89483,610,861.2
非流动负债:
非流动负债合计94,180,359.3795,539,444.7395,917,614.1596,088,416.94
负债合计583,094,474.71674,142,399.68554,084,889.04579,699,278.14
所有者权益(或股东权益):
归属于母公司股东权益合计3,047,178,827.012,985,467,836.152,984,717,139.322,907,655,225.72
股东权益合计3,048,673,545.222,986,992,461.452,986,240,012.232,909,108,743.41
负债和股东权益合计3,631,768,019.933,661,134,861.133,540,324,901.273,488,808,021.55
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计147,928,203.21,217,975,283.51805,896,136.18580,562,028.55
经营活动现金流出小计158,856,257.63813,135,358.43631,329,092.07439,075,645.45
经营活动产生的现金流量净额-10,928,054.43404,839,925.08174,567,044.11141,486,383.1
投资活动产生的现金流量:
投资活动现金流入小计-1,704,632,166.86750,642,109.04750,642,109.04
投资活动现金流出小计19,994,053.21,816,327,974.35930,692,401.83892,316,695.86
投资活动产生的现金流量净额-19,994,053.2-111,695,807.49-180,050,292.79-141,674,586.82
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计81,409,241.9529,514,440.2327,383,961.438,618,899.63
筹资活动产生的现金流量净额-81,409,241.95-29,514,440.23-27,383,961.43-8,618,899.63
汇率变动对现金及现金等价物的影响-320,760.32-174,841.04-248,760.77-275,701.18
现金及现金等价物净增加额-112,652,109.9263,454,836.32-33,115,970.88-9,082,804.53
期末现金及现金等价物余额1,289,820,377.081,402,472,486.981,105,901,679.781,129,934,846.13
补充资料:
现金及现金等价物的净增加额-263,454,836.32--9,082,804.53
最新报告期:2026-04-30
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华泰证券代雯,孔垂岩,王殷杰0.891.081.312026-04-30
中信建投刘慧彬,李虹达,王在存,贺菊颖0.871.051.272026-04-28
东方证券伍云飞0.881.061.282026-04-09
中银证券刘恩阳0.901.101.302026-04-07
华泰证券代雯,孔垂岩,王殷杰0.891.081.312026-04-01
TOP↑